Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Ascendant Hedge Fund ETF Lifts Upstart ETF Issuer

BY | ETF Database
09/23/2025 | 453 VIEWS
On the list of ultra-competitive U.S. industries, ETFs merit a place in the conversation. It’s an understatement to stay it’s tough for issuers of new ETF products to stand out. Many try. Few succeed.With help from the Unlimited HFGM Global Macro ETF (HFGM ), Bob Elliott’s Unlimited ETFs is showing it’s a worthy competitor in the ETF arena. HFGM, which replicates hedge fund strategies via the ETF wrapper, recently topped $50 million in assets under management (AUM), pushing Unlimited’s AUM tally north of $100 million. For those thinking “What’s the big deal?,” consider the following. HFGM competes against a slew of established rivals, and it’s flirting with $52 million in AUM after coming to market in April. That’s a solid trajectory. Add to that, three of Unlimited’s four ETFs, including HFGM, came to market this year. That is to say, the issuer is on the right path. On a recent webcast hosted by VettaFi Investment Strategist Cinthia Murphy, Elliott discussed Unlimited’s success and how HFGM is playing a role in that equation. Among points of interest, Elliott and Murphy delved into the convenience of alternative investments like HFGM in the ETF wrapper and how hedge fund replication strategies can benefit advisors and investors.Honing in on HFGMWhile HFGM may fit the bill as a “hedge fund ETF,” it’s important the ETF isn’t a direct investment in a hedge fund. In fact, the Unlimited ETF doesn’t invest in hedge funds or the underlying holds of those money managers. HFGM “will not engage in certain types of investment activities that are permissible for hedge funds. For example, hedge funds may use more leverage than the Fund, and hedge funds may invest a greater percentage of their assets in illiquid investments as compared to the Fund,” according to Unlimited. However, HFGM does hedge because it holds both long and short positions, though that methodology doesn’t imply the ETF’s portfolio is overly exotic. It’s not. In fact, top holdings in HFGM are approachable to a broad swath of investors and include instruments such as bond, commodity, currency and equity futures as well as a pair of well-known fixed income ETFs. Increasing the appeal of HFGM to advisors and investors is the correlation conundrum. In recent years, some asset classes have seen previously low correlations increase, meaning market participants weren’t getting the desired diversification when mixing those assets in portfolios. Alternative strategies such as HFGM typically sport noticeably lower correlations to equities and fixed income and could serve as enhancers to portfolios that lean heavily into stocks and bonds. For more news, information, and analysis, visit our Portfolio Strategies Content Hub.

More Commentary

Top Performing Leveraged/Inverse ETFs: 09/28/2025
BY | ETF Database
10/01/2025 | 257 VIEWS
Buy on the Dip Prospects: October 1 Edition
BY | ETF Database
10/01/2025 | 280 VIEWS
Sell on the Pop Prospects: September 24 Edition
BY | ETF Database
09/26/2025 | 443 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.